Marimed (MRMD) Land & Improvements (2015 - 2016)

Marimed (MRMD) reported Land & Improvements of $686802.0 for Q3 2016, up 283.27% quarter-over-quarter from $179196.0 in Q2 2016.

Marimed (MRMD) Land & Improvements (2015 - 2016) Analysis & Trends

Marimed (MRMD) has 2 years of Land & Improvements data on file, last reported at $686802.0 in Q3 2016.

  • Land & Improvements for Q3 2016 came in at $686802.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2016 was $686802.0 (changed N/A YoY), and the FY2015 annual result was $71488.0, changed N/A from the prior year.
  • Land & Improvements grew to $686802.0 in Q3 2016 per MRMD's latest filing, from $179196.0 in the prior quarter.
  • Over five years, Land & Improvements peaked at $686802.0 in Q3 2016 and troughed at $71488.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Marimed - - 15.28 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2016 686,802.00
Jun 30, 2016 179,196.00
Mar 31, 2016 89,988.00
Dec 31, 2015 71,488.00